Retinal Stem Cells for Transplantation in Macular Degeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2008 - March 31, 2010
Grant ID
M2008013
Goals
In this study, the researchers will isolate mouse adult retinal stem cells and enrich them for cone photoreceptors by manipulating specific cellular pathways as through a cell sorting technique. They will also test the ability of transplanted adult retinal stem cells to restore vision in mice that lack functioning cone photoreceptors.
Summary
Normal vision relies on the function of cells called cone photoreceptors and retinal pigment epithelial cells. In patients with AMD these cells die. Current treatments are effective in slowing down AMD, but they do not reverse the degeneration that has already occurred. To restore normal vision, these lost cells will need to be replaced. Stem cell therapy offers the promise of an inexhaustible supply of retinal cells that can be used for transplant into eyes affected by AMD. These researchers have shown that isolated retinal stem cells can generate cone photoreceptors and retinal pigment epithelial cells. When these retinal stem cells are transplanted into mouse eyes, they are able to integrate into the host retina and develop correctly.
Related Grants
Macular Degeneration Research
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University
Macular Degeneration Research
New Drug Delivery Approach to Transform Macular Degeneration Treatment
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Daisy Shu, PhD
Current Organization
University of New South Wales
New Drug Delivery Approach to Transform Macular Degeneration Treatment
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Daisy Shu, PhD
Current Organization
University of New South Wales
Macular Degeneration Research
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Current Organization
Institute of Molecular and Clinical Ophthalmology Basel (Switzerland)
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Current Organization
Institute of Molecular and Clinical Ophthalmology Basel (Switzerland)